Thalys Medical Technology Group Inc
SSE:603716
Thalys Medical Technology Group Inc
Revenue
Thalys Medical Technology Group Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Thalys Medical Technology Group Inc
SSE:603716
|
Revenue
¥2.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Revenue
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Revenue
¥6.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
266%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Revenue
¥5.5B
|
CAGR 3-Years
33%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Revenue
¥49.7B
|
CAGR 3-Years
53%
|
CAGR 5-Years
65%
|
CAGR 10-Years
50%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Revenue
¥1.9B
|
CAGR 3-Years
51%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
See Also
What is Thalys Medical Technology Group Inc's Revenue?
Revenue
2.1B
CNY
Based on the financial report for Sep 30, 2023, Thalys Medical Technology Group Inc's Revenue amounts to 2.1B CNY.
What is Thalys Medical Technology Group Inc's Revenue growth rate?
Revenue CAGR 5Y
11%
Over the last year, the Revenue growth was -18%. The average annual Revenue growth rates for Thalys Medical Technology Group Inc have been 3% over the past three years , 11% over the past five years .